In Re Vitamin C Antitrust Litigation

810 F. Supp. 2d 522, 2011 WL 3918165
CourtDistrict Court, E.D. New York
DecidedSeptember 6, 2011
Docket1:06-cv-01738
StatusPublished
Cited by9 cases

This text of 810 F. Supp. 2d 522 (In Re Vitamin C Antitrust Litigation) is published on Counsel Stack Legal Research, covering District Court, E.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Vitamin C Antitrust Litigation, 810 F. Supp. 2d 522, 2011 WL 3918165 (E.D.N.Y. 2011).

Opinion

*524 MEMORANDUM DECISION AND ORDER

COGAN, District Judge.

Plaintiffs have filed suit against Chinese vitamin C manufacturers, alleging that they engaged in an illegal cartel to fix prices and limit supply for exports, including those to the United States. 1 The four main defendants are Hebei Welcome Pharmaceutical Co. Ltd. (“Hebei Welcome” or “Welcome”), Aland (Jiangsu) Nutraceutical Co., Ltd. (“Jiangsu Jiangshan” or “JJPC”), Northeast Pharmaceutical Co. Ltd. (“NEPG” or “Northeast”) and Weisheng Pharmaceutical Co. Ltd. (“Weisheng”) (collectively “defendants”). 2

Plaintiffs bring this putative class action under Section 1 of the Sherman Act and Sections 4 and 16 of the Clayton Act, 15 U.S.C. §§ 4, 16. Plaintiffs seek treble damages and injunctive relief against all defendants except for Northeast, against whom only injunctive relief is sought.

Defendants do not dispute that the cartel agreements at issue violate the antitrust laws save for one primary defense: that they were compelled by the Chinese government to fix prices. They have filed a motion for summary judgment based upon that defense and the related doctrines of comity and act of state.

The three doctrines upon which defendants rely recognize that a foreign national should not be placed between the rock of its own local law and the hard place of U.S. law. However, that concern is insufficient to protect defendants from their acknowl *525 edged violation of the antitrust laws because, here, there is no rock and no hard place. The Chinese law relied upon by defendants did not compel their illegal conduct. Although defendants and the Chinese government argue to the contrary, the provisions of Chinese law before me do not support their position, which is also belied by the factual record. I decline to defer to the Chinese government’s statements to the court regarding Chinese law.

Accordingly, defendants’ motion for summary judgment is denied.

(1)

BACKGROUND

By November 2001, defendants, who faced much lower manufacturing costs than their foreign competitors, had captured over 60% of the worldwide market for vitamin C. China’s share of vitamin C imports to the United States rose from 60% in 1997 to over 80% by 2002. Around this time, a number of foreign competitors discontinued or reduced production.

It is not disputed that defendants fixed prices and agreed on output restrictions. Defendants are members of the Chamber of Commerce of Medicines and Health Products Importers and Exporters (“the Chamber”). Many of the agreements at issue were reached at meetings of the Chamber and appear to have been, at the very least, facilitated by the Chamber. Defendants, however, contend that the Chamber is a government-supervised entity through which the Chinese government exercises its regulatory authority over vitamin C exports and that all of the agreements at issue were compelled by the Chinese government.

After plaintiffs filed suit, defendants moved to dismiss the complaint, invoking the foreign sovereign compulsion defense, the act of state doctrine and the doctrine of international comity. The Ministry of Commerce of the People’s Republic of China (“The Ministry”), which is the highest authority in China authorized to regulate foreign trade, 3 filed an amicus brief in support of defendants’ motion, explaining the Chinese government’s regulation of vitamin C exports. The Ministry “formulates strategies, guidelines and policies concerning domestic and foreign trade and international economic cooperation, drafts and enforces laws and regulations governing domestic and foreign trade, and regulates market operation to achieve an integrated, competitive and orderly market system.” The Ministry is equivalent to a cabinet level department in the United States. According to the Ministry, defendants’ actions were compelled by the Chinese government.

Judge David G. Trager denied defendants’ motion to dismiss, finding the record, at that time, to be “simply too ambiguous to foreclose further inquiry into the voluntariness of defendants’ actions.” 4 In re Vitamin C Antitrust Litig., 584 F.Supp.2d 546, 559 (E.D.N.Y.2008). With the benefit of some discovery, plaintiffs had offered evidence suggesting that defendants’ agreements may have been voluntary. In addition, Judge Trager was concerned with the possibility that the cartel and purportedly compulsive governmental regulations at issue had been established at the behest of defendants and the Chinese government had simply given its “imprimatur.”

*526 Defendants now move for summary judgment on their three related defenses. Although the initial complaint in this suit was filed in January 2005, the operative complaint for the purposes of the instant motion covers the time period from December 1, 2001 through December 2, 2008.

(2)

CHINESE LAW

I. China’s Economic Transition and the Establishment of the Chambers

In 1978, China began to transition from a planned economy to a “socialist market economy.” During the planned economy era, the control of foreign trade was centralized under the Ministry and all foreign trade was conducted through state-owned import and trade companies according to state trade plans. After some reforms in the mid-1980’s led to aggressive forms of competition, the government imposed new administrative controls, which involved the establishment of the various China Chambers of Commerce for Import and Export (“Chambers”), including the Chamber. According to defendants’ Chinese law expert, Professor Shen Sibao, 5 the formation of the Chambers was part of China’s “important national policy which requires Chinese exporting companies to ‘unite and act in unison in foreign trade.’ ”

The authority to regulate import and export commerce was eventually transferred from the state-owned trading companies to these Chambers. When the Chambers were created, they were staffed with personnel transferred directly from the government.

The Chambers were given both governmental functions, which had previously been performed by the Ministry, and private functions. The governmental functions included, inter alia, responding to foreign anti-dumping charges and industry “coordination.” The private functions of the Chambers included organizing trade fairs, conducting market research and “mediating” trade disputes.

II. 1996 Interim Regulations

The first governmental directive cited in the Ministry’s brief is the Interim Regulations of the Ministry on Punishment for Conduct of Exporting at Lower-than-Normal Price (“1996 Interim Regulations”), which were promulgated on March 20, 1996. 6

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Celestin v. Caribbean Air Mail, Inc.
30 F.4th 133 (Second Circuit, 2022)
Leonard v. Lentz
288 F. Supp. 3d 945 (N.D. Iowa, 2018)
Wultz v. Bank of China Ltd.
942 F. Supp. 2d 452 (S.D. New York, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
810 F. Supp. 2d 522, 2011 WL 3918165, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-vitamin-c-antitrust-litigation-nyed-2011.